Medical Devices & Consumables
Global Medical Surgical Artificial Heart Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 608250
- Pages: 155
- Figures: 165
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Medical Surgical Artificial Heart Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Corcym
CryoLife
Braile Biomédica
TTK Healthcare
Colibri Heart Valve
JenaValve Technology
Meril Life Sciences
Beijing Balance Medical
CardiMED
Segment by Type
Mechanical Valve
Biological Valve
Segment by Application
Hospital
Clinic
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Medical Surgical Artificial Heart Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Medical Surgical Artificial Heart Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Corcym
CryoLife
Braile Biomédica
TTK Healthcare
Colibri Heart Valve
JenaValve Technology
Meril Life Sciences
Beijing Balance Medical
CardiMED
Segment by Type
Mechanical Valve
Biological Valve
Segment by Application
Hospital
Clinic
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Medical Surgical Artificial Heart Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Medical Surgical Artificial Heart Valve: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Surgical Artificial Heart Valve Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mechanical Valve
1.2.3 Biological Valve
1.3 Market Segmentation by Application
1.3.1 Global Medical Surgical Artificial Heart Valve Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Surgical Artificial Heart Valve Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Surgical Artificial Heart Valve Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Medical Surgical Artificial Heart Valve Sales Estimates and Forecasts 2020-2031
2.4 Global Medical Surgical Artificial Heart Valve Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Medical Surgical Artificial Heart Valve Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Medical Surgical Artificial Heart Valve Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mechanical Valve Market Size by Manufacturers
3.5.2 Biological Valve Market Size by Manufacturers
3.6 Global Medical Surgical Artificial Heart Valve Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medical Surgical Artificial Heart Valve Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Medical Surgical Artificial Heart Valve Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medical Surgical Artificial Heart Valve Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Medical Surgical Artificial Heart Valve Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
6.4 North America Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medical Surgical Artificial Heart Valve Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
7.4 Europe Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medical Surgical Artificial Heart Valve Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Medical Surgical Artificial Heart Valve Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
9.4 Central and South America Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medical Surgical Artificial Heart Valve Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medical Surgical Artificial Heart Valve Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.1.4 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.1.6 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.1.7 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.1.8 Edwards Lifesciences Medical Surgical Artificial Heart Valve SWOT Analysis
11.1.9 Edwards Lifesciences Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.2.4 Medtronic Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.2.6 Medtronic Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.2.7 Medtronic Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.2.8 Medtronic Medical Surgical Artificial Heart Valve SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Corporation Information
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.3.4 Boston Scientific Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.3.6 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.3.7 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.3.8 Boston Scientific Medical Surgical Artificial Heart Valve SWOT Analysis
11.3.9 Boston Scientific Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Business Overview
11.4.3 Abbott Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.4.4 Abbott Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abbott Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.4.6 Abbott Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.4.7 Abbott Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.4.8 Abbott Medical Surgical Artificial Heart Valve SWOT Analysis
11.4.9 Abbott Recent Developments
11.5 Corcym
11.5.1 Corcym Corporation Information
11.5.2 Corcym Business Overview
11.5.3 Corcym Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.5.4 Corcym Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Corcym Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.5.6 Corcym Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.5.7 Corcym Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.5.8 Corcym Medical Surgical Artificial Heart Valve SWOT Analysis
11.5.9 Corcym Recent Developments
11.6 CryoLife
11.6.1 CryoLife Corporation Information
11.6.2 CryoLife Business Overview
11.6.3 CryoLife Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.6.4 CryoLife Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 CryoLife Recent Developments
11.7 Braile Biomédica
11.7.1 Braile Biomédica Corporation Information
11.7.2 Braile Biomédica Business Overview
11.7.3 Braile Biomédica Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.7.4 Braile Biomédica Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Braile Biomédica Recent Developments
11.8 TTK Healthcare
11.8.1 TTK Healthcare Corporation Information
11.8.2 TTK Healthcare Business Overview
11.8.3 TTK Healthcare Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.8.4 TTK Healthcare Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 TTK Healthcare Recent Developments
11.9 Colibri Heart Valve
11.9.1 Colibri Heart Valve Corporation Information
11.9.2 Colibri Heart Valve Business Overview
11.9.3 Colibri Heart Valve Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.9.4 Colibri Heart Valve Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Colibri Heart Valve Recent Developments
11.10 JenaValve Technology
11.10.1 JenaValve Technology Corporation Information
11.10.2 JenaValve Technology Business Overview
11.10.3 JenaValve Technology Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.10.4 JenaValve Technology Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 JenaValve Technology Recent Developments
11.11 Meril Life Sciences
11.11.1 Meril Life Sciences Corporation Information
11.11.2 Meril Life Sciences Business Overview
11.11.3 Meril Life Sciences Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.11.4 Meril Life Sciences Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Meril Life Sciences Recent Developments
11.12 Beijing Balance Medical
11.12.1 Beijing Balance Medical Corporation Information
11.12.2 Beijing Balance Medical Business Overview
11.12.3 Beijing Balance Medical Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.12.4 Beijing Balance Medical Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Beijing Balance Medical Recent Developments
11.13 CardiMED
11.13.1 CardiMED Corporation Information
11.13.2 CardiMED Business Overview
11.13.3 CardiMED Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.13.4 CardiMED Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 CardiMED Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Medical Surgical Artificial Heart Valve Industry Chain
12.2 Medical Surgical Artificial Heart Valve Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Medical Surgical Artificial Heart Valve Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Medical Surgical Artificial Heart Valve Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medical Surgical Artificial Heart Valve Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medical Surgical Artificial Heart Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Medical Surgical Artificial Heart Valve: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Surgical Artificial Heart Valve Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mechanical Valve
1.2.3 Biological Valve
1.3 Market Segmentation by Application
1.3.1 Global Medical Surgical Artificial Heart Valve Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Surgical Artificial Heart Valve Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Surgical Artificial Heart Valve Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Medical Surgical Artificial Heart Valve Sales Estimates and Forecasts 2020-2031
2.4 Global Medical Surgical Artificial Heart Valve Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Medical Surgical Artificial Heart Valve Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Medical Surgical Artificial Heart Valve Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mechanical Valve Market Size by Manufacturers
3.5.2 Biological Valve Market Size by Manufacturers
3.6 Global Medical Surgical Artificial Heart Valve Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medical Surgical Artificial Heart Valve Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Medical Surgical Artificial Heart Valve Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medical Surgical Artificial Heart Valve Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Medical Surgical Artificial Heart Valve Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
6.4 North America Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medical Surgical Artificial Heart Valve Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
7.4 Europe Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medical Surgical Artificial Heart Valve Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Medical Surgical Artificial Heart Valve Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
9.4 Central and South America Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medical Surgical Artificial Heart Valve Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Medical Surgical Artificial Heart Valve Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Medical Surgical Artificial Heart Valve Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medical Surgical Artificial Heart Valve Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.1.4 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.1.6 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.1.7 Edwards Lifesciences Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.1.8 Edwards Lifesciences Medical Surgical Artificial Heart Valve SWOT Analysis
11.1.9 Edwards Lifesciences Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.2.4 Medtronic Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.2.6 Medtronic Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.2.7 Medtronic Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.2.8 Medtronic Medical Surgical Artificial Heart Valve SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Corporation Information
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.3.4 Boston Scientific Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.3.6 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.3.7 Boston Scientific Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.3.8 Boston Scientific Medical Surgical Artificial Heart Valve SWOT Analysis
11.3.9 Boston Scientific Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Business Overview
11.4.3 Abbott Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.4.4 Abbott Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abbott Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.4.6 Abbott Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.4.7 Abbott Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.4.8 Abbott Medical Surgical Artificial Heart Valve SWOT Analysis
11.4.9 Abbott Recent Developments
11.5 Corcym
11.5.1 Corcym Corporation Information
11.5.2 Corcym Business Overview
11.5.3 Corcym Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.5.4 Corcym Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Corcym Medical Surgical Artificial Heart Valve Sales by Product in 2024
11.5.6 Corcym Medical Surgical Artificial Heart Valve Sales by Application in 2024
11.5.7 Corcym Medical Surgical Artificial Heart Valve Sales by Geographic Area in 2024
11.5.8 Corcym Medical Surgical Artificial Heart Valve SWOT Analysis
11.5.9 Corcym Recent Developments
11.6 CryoLife
11.6.1 CryoLife Corporation Information
11.6.2 CryoLife Business Overview
11.6.3 CryoLife Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.6.4 CryoLife Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 CryoLife Recent Developments
11.7 Braile Biomédica
11.7.1 Braile Biomédica Corporation Information
11.7.2 Braile Biomédica Business Overview
11.7.3 Braile Biomédica Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.7.4 Braile Biomédica Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Braile Biomédica Recent Developments
11.8 TTK Healthcare
11.8.1 TTK Healthcare Corporation Information
11.8.2 TTK Healthcare Business Overview
11.8.3 TTK Healthcare Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.8.4 TTK Healthcare Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 TTK Healthcare Recent Developments
11.9 Colibri Heart Valve
11.9.1 Colibri Heart Valve Corporation Information
11.9.2 Colibri Heart Valve Business Overview
11.9.3 Colibri Heart Valve Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.9.4 Colibri Heart Valve Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Colibri Heart Valve Recent Developments
11.10 JenaValve Technology
11.10.1 JenaValve Technology Corporation Information
11.10.2 JenaValve Technology Business Overview
11.10.3 JenaValve Technology Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.10.4 JenaValve Technology Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 JenaValve Technology Recent Developments
11.11 Meril Life Sciences
11.11.1 Meril Life Sciences Corporation Information
11.11.2 Meril Life Sciences Business Overview
11.11.3 Meril Life Sciences Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.11.4 Meril Life Sciences Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Meril Life Sciences Recent Developments
11.12 Beijing Balance Medical
11.12.1 Beijing Balance Medical Corporation Information
11.12.2 Beijing Balance Medical Business Overview
11.12.3 Beijing Balance Medical Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.12.4 Beijing Balance Medical Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Beijing Balance Medical Recent Developments
11.13 CardiMED
11.13.1 CardiMED Corporation Information
11.13.2 CardiMED Business Overview
11.13.3 CardiMED Medical Surgical Artificial Heart Valve Product Models, Descriptions and Specifications
11.13.4 CardiMED Medical Surgical Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 CardiMED Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Medical Surgical Artificial Heart Valve Industry Chain
12.2 Medical Surgical Artificial Heart Valve Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Medical Surgical Artificial Heart Valve Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Medical Surgical Artificial Heart Valve Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medical Surgical Artificial Heart Valve Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medical Surgical Artificial Heart Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Medical Surgical Artificial Heart Valve Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medical Surgical Artificial Heart Valve Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Medical Surgical Artificial Heart Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Medical Surgical Artificial Heart Valve Sales by Region (2020-2025) & (K Units)
Table 8. Global Medical Surgical Artificial Heart Valve Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Medical Surgical Artificial Heart Valve Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Medical Surgical Artificial Heart Valve Sales Share by Manufacturers (2020-2025)
Table 12. Global Medical Surgical Artificial Heart Valve Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Medical Surgical Artificial Heart Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Surgical Artificial Heart Valve as of 2024)
Table 16. Global Medical Surgical Artificial Heart Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Medical Surgical Artificial Heart Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Medical Surgical Artificial Heart Valve Manufacturing Base and Headquarters
Table 19. Global Medical Surgical Artificial Heart Valve Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Medical Surgical Artificial Heart Valve Sales by Type (2020-2025) & (K Units)
Table 23. Global Medical Surgical Artificial Heart Valve Sales by Type (2026-2031) & (K Units)
Table 24. Global Medical Surgical Artificial Heart Valve Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Medical Surgical Artificial Heart Valve Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Medical Surgical Artificial Heart Valve ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Medical Surgical Artificial Heart Valve Sales by Application (2020-2025) & (K Units)
Table 29. Global Medical Surgical Artificial Heart Valve Sales by Application (2026-2031) & (K Units)
Table 30. Medical Surgical Artificial Heart Valve High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Medical Surgical Artificial Heart Valve Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Medical Surgical Artificial Heart Valve Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Medical Surgical Artificial Heart Valve ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 37. North America Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 40. Europe Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 45. Southeast Asia Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Medical Surgical Artificial Heart Valve Investment Opportunities and Key Challenges
Table 47. Central and South America Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Medical Surgical Artificial Heart Valve Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Edwards Lifesciences Corporation Information
Table 51. Edwards Lifesciences Description and Major Businesses
Table 52. Edwards Lifesciences Product Models, Descriptions and Specifications
Table 53. Edwards Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Edwards Lifesciences Sales Value Proportion by Product in 2024
Table 55. Edwards Lifesciences Sales Value Proportion by Application in 2024
Table 56. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
Table 57. Edwards Lifesciences Medical Surgical Artificial Heart Valve SWOT Analysis
Table 58. Edwards Lifesciences Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Medical Surgical Artificial Heart Valve SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Boston Scientific Corporation Information
Table 69. Boston Scientific Description and Major Businesses
Table 70. Boston Scientific Product Models, Descriptions and Specifications
Table 71. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Boston Scientific Sales Value Proportion by Product in 2024
Table 73. Boston Scientific Sales Value Proportion by Application in 2024
Table 74. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 75. Boston Scientific Medical Surgical Artificial Heart Valve SWOT Analysis
Table 76. Boston Scientific Recent Developments
Table 77. Abbott Corporation Information
Table 78. Abbott Description and Major Businesses
Table 79. Abbott Product Models, Descriptions and Specifications
Table 80. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Abbott Sales Value Proportion by Product in 2024
Table 82. Abbott Sales Value Proportion by Application in 2024
Table 83. Abbott Sales Value Proportion by Geographic Area in 2024
Table 84. Abbott Medical Surgical Artificial Heart Valve SWOT Analysis
Table 85. Abbott Recent Developments
Table 86. Corcym Corporation Information
Table 87. Corcym Description and Major Businesses
Table 88. Corcym Product Models, Descriptions and Specifications
Table 89. Corcym Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Corcym Sales Value Proportion by Product in 2024
Table 91. Corcym Sales Value Proportion by Application in 2024
Table 92. Corcym Sales Value Proportion by Geographic Area in 2024
Table 93. Corcym Medical Surgical Artificial Heart Valve SWOT Analysis
Table 94. Corcym Recent Developments
Table 95. CryoLife Corporation Information
Table 96. CryoLife Description and Major Businesses
Table 97. CryoLife Product Models, Descriptions and Specifications
Table 98. CryoLife Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. CryoLife Recent Developments
Table 100. Braile Biomédica Corporation Information
Table 101. Braile Biomédica Description and Major Businesses
Table 102. Braile Biomédica Product Models, Descriptions and Specifications
Table 103. Braile Biomédica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Braile Biomédica Recent Developments
Table 105. TTK Healthcare Corporation Information
Table 106. TTK Healthcare Description and Major Businesses
Table 107. TTK Healthcare Product Models, Descriptions and Specifications
Table 108. TTK Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. TTK Healthcare Recent Developments
Table 110. Colibri Heart Valve Corporation Information
Table 111. Colibri Heart Valve Description and Major Businesses
Table 112. Colibri Heart Valve Product Models, Descriptions and Specifications
Table 113. Colibri Heart Valve Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Colibri Heart Valve Recent Developments
Table 115. JenaValve Technology Corporation Information
Table 116. JenaValve Technology Description and Major Businesses
Table 117. JenaValve Technology Product Models, Descriptions and Specifications
Table 118. JenaValve Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. JenaValve Technology Recent Developments
Table 120. Meril Life Sciences Corporation Information
Table 121. Meril Life Sciences Description and Major Businesses
Table 122. Meril Life Sciences Product Models, Descriptions and Specifications
Table 123. Meril Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Meril Life Sciences Recent Developments
Table 125. Beijing Balance Medical Corporation Information
Table 126. Beijing Balance Medical Description and Major Businesses
Table 127. Beijing Balance Medical Product Models, Descriptions and Specifications
Table 128. Beijing Balance Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Beijing Balance Medical Recent Developments
Table 130. CardiMED Corporation Information
Table 131. CardiMED Description and Major Businesses
Table 132. CardiMED Product Models, Descriptions and Specifications
Table 133. CardiMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. CardiMED Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Surgical Artificial Heart Valve Product Picture
Figure 2. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mechanical Valve Product Picture
Figure 4. Biological Valve Product Picture
Figure 5. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Medical Surgical Artificial Heart Valve Report Years Considered
Figure 9. Global Medical Surgical Artificial Heart Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 11. Global Medical Surgical Artificial Heart Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Region (2020-2031)
Figure 13. Global Medical Surgical Artificial Heart Valve Sales (2020-2031) & (K Units)
Figure 14. Global Medical Surgical Artificial Heart Valve Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Medical Surgical Artificial Heart Valve Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Medical Surgical Artificial Heart Valve Sales Volume Market Share in 2024
Figure 17. Global Medical Surgical Artificial Heart Valve Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Mechanical Valve Revenue Market Share by Manufacturer in 2024
Figure 20. Biological Valve Revenue Market Share by Manufacturer in 2024
Figure 21. Global Medical Surgical Artificial Heart Valve Sales Market Share by Type (2020-2031)
Figure 22. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Type (2020-2031)
Figure 23. Global Medical Surgical Artificial Heart Valve Sales Market Share by Application (2020-2031)
Figure 24. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Application (2020-2031)
Figure 25. North America Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 26. North America Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 28. North America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 38. Europe Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 43. France Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 58. India Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 79. Medical Surgical Artificial Heart Valve Industry Chain Mapping
Figure 80. Regional Medical Surgical Artificial Heart Valve Manufacturing Base Distribution (%)
Figure 81. Global Medical Surgical Artificial Heart Valve Production Market Share by Region (2020-2031)
Figure 82. Medical Surgical Artificial Heart Valve Production Process
Figure 83. Regional Medical Surgical Artificial Heart Valve Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Table 1. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Medical Surgical Artificial Heart Valve Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medical Surgical Artificial Heart Valve Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Medical Surgical Artificial Heart Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Medical Surgical Artificial Heart Valve Sales by Region (2020-2025) & (K Units)
Table 8. Global Medical Surgical Artificial Heart Valve Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Medical Surgical Artificial Heart Valve Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Medical Surgical Artificial Heart Valve Sales Share by Manufacturers (2020-2025)
Table 12. Global Medical Surgical Artificial Heart Valve Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Medical Surgical Artificial Heart Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Surgical Artificial Heart Valve as of 2024)
Table 16. Global Medical Surgical Artificial Heart Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Medical Surgical Artificial Heart Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Medical Surgical Artificial Heart Valve Manufacturing Base and Headquarters
Table 19. Global Medical Surgical Artificial Heart Valve Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Medical Surgical Artificial Heart Valve Sales by Type (2020-2025) & (K Units)
Table 23. Global Medical Surgical Artificial Heart Valve Sales by Type (2026-2031) & (K Units)
Table 24. Global Medical Surgical Artificial Heart Valve Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Medical Surgical Artificial Heart Valve Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Medical Surgical Artificial Heart Valve ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Medical Surgical Artificial Heart Valve Sales by Application (2020-2025) & (K Units)
Table 29. Global Medical Surgical Artificial Heart Valve Sales by Application (2026-2031) & (K Units)
Table 30. Medical Surgical Artificial Heart Valve High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Medical Surgical Artificial Heart Valve Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Medical Surgical Artificial Heart Valve Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Medical Surgical Artificial Heart Valve ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 37. North America Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 40. Europe Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Medical Surgical Artificial Heart Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Medical Surgical Artificial Heart Valve Growth Accelerators and Market Barriers
Table 45. Southeast Asia Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Medical Surgical Artificial Heart Valve Investment Opportunities and Key Challenges
Table 47. Central and South America Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Medical Surgical Artificial Heart Valve Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Medical Surgical Artificial Heart Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Edwards Lifesciences Corporation Information
Table 51. Edwards Lifesciences Description and Major Businesses
Table 52. Edwards Lifesciences Product Models, Descriptions and Specifications
Table 53. Edwards Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Edwards Lifesciences Sales Value Proportion by Product in 2024
Table 55. Edwards Lifesciences Sales Value Proportion by Application in 2024
Table 56. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
Table 57. Edwards Lifesciences Medical Surgical Artificial Heart Valve SWOT Analysis
Table 58. Edwards Lifesciences Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Medical Surgical Artificial Heart Valve SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Boston Scientific Corporation Information
Table 69. Boston Scientific Description and Major Businesses
Table 70. Boston Scientific Product Models, Descriptions and Specifications
Table 71. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Boston Scientific Sales Value Proportion by Product in 2024
Table 73. Boston Scientific Sales Value Proportion by Application in 2024
Table 74. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 75. Boston Scientific Medical Surgical Artificial Heart Valve SWOT Analysis
Table 76. Boston Scientific Recent Developments
Table 77. Abbott Corporation Information
Table 78. Abbott Description and Major Businesses
Table 79. Abbott Product Models, Descriptions and Specifications
Table 80. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Abbott Sales Value Proportion by Product in 2024
Table 82. Abbott Sales Value Proportion by Application in 2024
Table 83. Abbott Sales Value Proportion by Geographic Area in 2024
Table 84. Abbott Medical Surgical Artificial Heart Valve SWOT Analysis
Table 85. Abbott Recent Developments
Table 86. Corcym Corporation Information
Table 87. Corcym Description and Major Businesses
Table 88. Corcym Product Models, Descriptions and Specifications
Table 89. Corcym Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Corcym Sales Value Proportion by Product in 2024
Table 91. Corcym Sales Value Proportion by Application in 2024
Table 92. Corcym Sales Value Proportion by Geographic Area in 2024
Table 93. Corcym Medical Surgical Artificial Heart Valve SWOT Analysis
Table 94. Corcym Recent Developments
Table 95. CryoLife Corporation Information
Table 96. CryoLife Description and Major Businesses
Table 97. CryoLife Product Models, Descriptions and Specifications
Table 98. CryoLife Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. CryoLife Recent Developments
Table 100. Braile Biomédica Corporation Information
Table 101. Braile Biomédica Description and Major Businesses
Table 102. Braile Biomédica Product Models, Descriptions and Specifications
Table 103. Braile Biomédica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Braile Biomédica Recent Developments
Table 105. TTK Healthcare Corporation Information
Table 106. TTK Healthcare Description and Major Businesses
Table 107. TTK Healthcare Product Models, Descriptions and Specifications
Table 108. TTK Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. TTK Healthcare Recent Developments
Table 110. Colibri Heart Valve Corporation Information
Table 111. Colibri Heart Valve Description and Major Businesses
Table 112. Colibri Heart Valve Product Models, Descriptions and Specifications
Table 113. Colibri Heart Valve Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Colibri Heart Valve Recent Developments
Table 115. JenaValve Technology Corporation Information
Table 116. JenaValve Technology Description and Major Businesses
Table 117. JenaValve Technology Product Models, Descriptions and Specifications
Table 118. JenaValve Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. JenaValve Technology Recent Developments
Table 120. Meril Life Sciences Corporation Information
Table 121. Meril Life Sciences Description and Major Businesses
Table 122. Meril Life Sciences Product Models, Descriptions and Specifications
Table 123. Meril Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Meril Life Sciences Recent Developments
Table 125. Beijing Balance Medical Corporation Information
Table 126. Beijing Balance Medical Description and Major Businesses
Table 127. Beijing Balance Medical Product Models, Descriptions and Specifications
Table 128. Beijing Balance Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Beijing Balance Medical Recent Developments
Table 130. CardiMED Corporation Information
Table 131. CardiMED Description and Major Businesses
Table 132. CardiMED Product Models, Descriptions and Specifications
Table 133. CardiMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. CardiMED Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Surgical Artificial Heart Valve Product Picture
Figure 2. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mechanical Valve Product Picture
Figure 4. Biological Valve Product Picture
Figure 5. Global Medical Surgical Artificial Heart Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Medical Surgical Artificial Heart Valve Report Years Considered
Figure 9. Global Medical Surgical Artificial Heart Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 11. Global Medical Surgical Artificial Heart Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Region (2020-2031)
Figure 13. Global Medical Surgical Artificial Heart Valve Sales (2020-2031) & (K Units)
Figure 14. Global Medical Surgical Artificial Heart Valve Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Medical Surgical Artificial Heart Valve Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Medical Surgical Artificial Heart Valve Sales Volume Market Share in 2024
Figure 17. Global Medical Surgical Artificial Heart Valve Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Mechanical Valve Revenue Market Share by Manufacturer in 2024
Figure 20. Biological Valve Revenue Market Share by Manufacturer in 2024
Figure 21. Global Medical Surgical Artificial Heart Valve Sales Market Share by Type (2020-2031)
Figure 22. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Type (2020-2031)
Figure 23. Global Medical Surgical Artificial Heart Valve Sales Market Share by Application (2020-2031)
Figure 24. Global Medical Surgical Artificial Heart Valve Revenue Market Share by Application (2020-2031)
Figure 25. North America Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 26. North America Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 28. North America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 38. Europe Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 43. France Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 58. India Medical Surgical Artificial Heart Valve Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Medical Surgical Artificial Heart Valve Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Medical Surgical Artificial Heart Valve Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Medical Surgical Artificial Heart Valve Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Medical Surgical Artificial Heart Valve Revenue (2020-2025) & (US$ Million)
Figure 79. Medical Surgical Artificial Heart Valve Industry Chain Mapping
Figure 80. Regional Medical Surgical Artificial Heart Valve Manufacturing Base Distribution (%)
Figure 81. Global Medical Surgical Artificial Heart Valve Production Market Share by Region (2020-2031)
Figure 82. Medical Surgical Artificial Heart Valve Production Process
Figure 83. Regional Medical Surgical Artificial Heart Valve Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232